Contact   |   Login
EquinYar Banner Image

EquinYar Electrolyte Balance™

Electrolyte Balance has several advantages such as Supplementing Electrolytes, Helping Regenerating Muscle Cells, Shielding Digestive System ( 5902596870171 , 5902596870539 )

The majority of electrolyte products available on the market are based on artificial components. EquinYar Electrolyte Balance™ is prepared using natural ingredients, namely cultures of Yarrowia lipolytica yeast containing high levels of bioavailable form of sodium, potassium, calcium and magnesium. Those naturally occurring elements contained in a low 40ml daily dose of Electrolyte Balance are sufficient to replace electrolytes lost through sweating in sport horses. An additional advantage of Electrolyte Balance is the effect of close to natural pH, which has a buffering and soothing effect on pH levels in the stomach. Finally, the addition of vitmin E increases the overall value of the product.

Electrolyte Balance has several advantages, such as:

Supplementing Electrolytes

Electrolyte Balance supplements the balance of elements lost through sweating, restores normal hydration and equalizes fluid levels. This further encourages horses to drink water and restores the appetite.

Helping Regenerating Muscle Cells

Vitamin E, a natural and strong antioxidant, protects muscle cells from lactic acid and free radicals, promotes fast regeneration of muscle cells, and shortens the post-exercise rest phase.

Shielding Digestive System

Close to neutral pH of Electrolyte Balance product stabilizes the digestive system by protecting the lining of the upper, non-glandular parts of horse's stomach, thus supporting normal digestive functions.

Target Animals: The product is recommended for sport horses after episodes of intensive sweating due to transportation, increasd training, competitions and/or hot weather conditions. This product is for periodical use.

Dosage: 40ml/day/horse of approximately 500kg body weight

Contact our Customer Support Department to find out how we can address your needs in your market.


Catalog Download:

To download the latest catalog for EquinYar, click here.



Quick Contact

Catalog Download:
To download the latest catalog for EquinYar, click here.



Deferoxamine Mesylate Market to Witness Robust Expansion by 2029 with Teva api, Chengdu Easton Biopharmaceuticals, Pharmapex Group
The Deferoxamine Mesylate Report is a unique record that gives a total judgment of the market in terms of future patterns, development factors, creation volume, CAGR estimation, net revenue, cost, and industry-approved market data.

Pharmapex's novel mastitis treatment offers hope to world farmers
Efficient feed-based mastitis treatment boosts livestock health with a unique microencapsulated technology.

FDA approves Farxiga to treat type 2 diabetes
The U.S. FDA today approved Farxiga (dapaglifozin) tablets to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
© , Pharmapex USA, A member of Apex Group of Companies, All Rights Reserved.